Evidence map›Paper›PMID 17442718›Full record

ArticleJournal of virology2007

Ty3 capsid mutations reveal early and late functions of the amino-terminal domain.

Liza S Z Larsen, Min Zhang, Nadejda Beliakova-Bethell, Virginia Bilanchone, Anne Lamsa, Kunio Nagashima, Rani Najdi, Kathryn Kosaka, Vuk Kovacevic, Jianlin Cheng and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Structure of the Ty3/Gypsy retrotransposon capsid and the evolution of retroviruses.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Liza S Z LarsenDepartment of Microbiology and Molecular Genetics, University of California, Irvine, CA 92697, USA.
Min Zhang
Nadejda Beliakova-Bethell
Virginia Bilanchone
Anne Lamsa
Kunio Nagashima
Rani Najdi
Kathryn Kosaka
Vuk Kovacevic
Jianlin Cheng
Pierre Baldi
G Wesley Hatfield
Suzanne Sandmeyer
University of California, Irvine · USScience Applications International Corporation (United States) · US

Funding

Biomedical Informatics Training ProgramT15LM007443 · NLM · UNIVERSITY OF CALIFORNIA-IRVINE · PI BALDI, PIERRE · 2002 to 2012
$9.3M
Ty3 Viruslike Particle Morphogenesis and Host InteractionsR01GM033281 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SANDMEYER, SUZANNE · 1985 to 2013
$4.7M
A Functional Census of p53 Cancer and Suppressor MutantsR01CA112560 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KAISER, PETER, LATHROP, RICHARD H · 2005 to 2013
$3.2M
Virus-host interactions: a multi-scale training programT32AI007319 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI SEMLER, BERT L, SHI, YONGSHENG · 1988 to 2024
$2.4M
Global Regulatory Networks in Escherichia ColiR01GM068903 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HATFIELD, G. WESLEY · 2003 to 2006
$1.3M
NCI NIH HHS CA112560NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO12400NCI NIH HHS R01 CA112560NIAID NIH HHS T32 AI007319NIAID NIH HHS T32-AI07319NIGMS NIH HHS GM33281NIGMS NIH HHS GM68903NIGMS NIH HHS R01 GM033281NIGMS NIH HHS R01 GM068903NLM NIH HHS LM07443-01NLM NIH HHS T15 LM007443
6 · The paper itself

Abstract

The Ty3 retrotransposon assembles into 50-nm virus-like particles that occur in large intracellular clusters in the case of wild-type (wt) Ty3. Within these particles, maturation of the Gag3 and Gag3-Pol3 polyproteins by Ty3 protease produces the structural proteins capsid (CA), spacer, and nucleocapsid. Secondary and tertiary structure predictions showed that, like retroviral CA, Ty3 CA contains a large amount of helical structure arranged in amino-terminal and carboxyl-terminal bundles. Twenty-six mutants in which alanines were substituted for native residues were used to study CA subdomain functions. Transposition was measured, and particle morphogenesis and localization were characterized by analysis of protein processing, cDNA production, genomic RNA protection, and sedimentation and by fluorescence and electron microscopy. These measures defined five groups of mutants. Proteins from each group could be sedimented in a large complex. Mutations in the amino-terminal domain reduced the formation of fluorescent Ty3 protein foci. In at least one major homology region mutant, Ty3 protein concentrated in foci but no wt clusters of particles were observed. One mutation in the carboxyl-terminal domain shifted assembly from spherical particles to long filaments. Two mutants formed foci separate from P bodies, the proposed sites of assembly, and formed defective particles. P-body association was therefore found to be not necessary for assembly but correlated with the production of functional particles. One mutation in the amino terminus blocked transposition after cDNA synthesis. Our data suggest that Ty3 proteins are concentrated first, assembly associated with P bodies occurs, and particle morphogenesis concludes with a post-reverse transcription, CA-dependent step. Particle formation was generally resistant to localized substitutions, possibly indicating that multiple domains are involved.

Indexed as

CapsidMutation, MissenseAmino Acid SubstitutionDNA, ComplementaryDNA Polymerase IIIGene Products, gagInclusion BodiesProtein Structure, SecondaryProtein Structure, TertiaryRetroelementsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsDNA, ComplementaryDNA Polymerase IIIGene Products, gagPOL3 protein, S cerevisiaeRetroelementsSaccharomyces cerevisiae Proteins

Identifiers

PMID17442718
PMCPMC1933270
OpenAlexW2143829319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.